Cohanzick Management, LLC Biote Corp. Transaction History

Cohanzick Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$5.27 - $6.9 $1.84 Million - $2.41 Million	-349,068 Reduced 69.68%	151,907 $1.03 Million
Q1 2023 May 12, 2023	BUY	$3.14 - $6.19 $1.19 Million - $2.35 Million	379,924 Added 313.85%	500,975 $3.1 Million
Q4 2022 Feb 13, 2023	SELL	$3.73 - $4.6 $2.69 Million - $3.32 Million	-721,006 Reduced 85.62%	121,051 $451,000
Q3 2022 Nov 10, 2022	BUY	$3.48 - $4.98 $1.55 Million - $2.21 Million	444,280 Added 111.69%	842,057 $3.6 Million
Q2 2022 Aug 12, 2022	BUY	$3.42 - $10.06 $1.36 Million - $4 Million	397,777 New	397,777 $1.5 Million

17.7M

Ticker BTMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 7,574,270
Market Cap $45.3M
Description
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...

Get notified when there are updates to the investment portfolio of Cohanzick Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cohanzick Management, LLC with notifications on news.